Improving Access to Overdose and Substance Use Disorder Care for People in the Criminal Legal System
Implementation and Translation Research Project Core
['FUNDING_OTHER'] · GEORGE MASON UNIVERSITY · NIH-11128729
This project aims to create better ways to deliver life-saving overdose prevention and substance use disorder treatments to people involved with the criminal legal system.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGE MASON UNIVERSITY (nih funded) |
| Locations | 1 site (FAIRFAX, UNITED STATES) |
| Trial ID | NIH-11128729 on ClinicalTrials.gov |
What this research studies
Many people involved with the criminal legal system face a high risk of overdose, and while effective treatments exist, they often don't reach everyone who needs them. This project is developing and testing a new model to help spread these proven prevention and treatment strategies more widely across criminal legal and public health systems. Our goal is to bridge the gap between researchers and practitioners, ensuring that life-changing innovations are adopted on a larger scale. By integrating different successful approaches, we hope to make it easier for agencies to implement these vital programs.
Who could benefit from this research
Good fit: This project is designed to benefit individuals with substance use disorders and those at risk of overdose who are involved with the criminal legal system.
Not a fit: Patients not at risk of overdose or not involved with the criminal legal system would not directly benefit from this specific implementation project.
Why it matters
Potential benefit: If successful, this work could significantly increase access to effective overdose prevention and substance use disorder treatments for vulnerable populations, potentially saving many lives.
How similar studies have performed: While specific models for large-scale implementation are still developing, many individual prevention and treatment interventions for substance use disorders have already shown success.
Where this research is happening
FAIRFAX, UNITED STATES
- GEORGE MASON UNIVERSITY — FAIRFAX, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOLFENTER, TODD DAVID — GEORGE MASON UNIVERSITY
- Study coordinator: MOLFENTER, TODD DAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.